- Home
- applications
- biopsy system
Refine by
Biopsy System Product Applications
5 applications found
In 2022, nearly 30,000 Alabama men and women will be diagnosed with cancer, and more than 10,000 will die from the disease. The Information is Power campaign facilitated through the HudsonAlpha Institute for Biotechnology has offered free or reduced-cost hereditary cancer risk testing to our community of Northern Alabama in collaboration with Kailos Genetics since 2015. Information is Power uses the Expedio™ Hereditary Cancer Screening Service to review 33 genes for genetic mutations that may increase your ...
ByKailos Genetics, LLC. based in Huntsville, ALABAMA (USA)
You need a complete answer to provide the best ...
ByBiocept based in San Diego, CALIFORNIA (USA)
Standard Biopsy Limitations Traditionally, men suspected of prostate cancer undergo systematic biopsies guided by ultrasound imaging. Because ultrasound offers poor cancer visualization, 12 random samples are taken without knowing if there is cancer and if so, where it is. As a result, the cancer is either missed entirely, or if detected, is difficult to determine the extent and severity. This leads to under treatment of men with serious disease and overtreatment of men with indolent disease.4 ...
ByFocal Healthcare based in Toronto, ONTARIO (CANADA)
A liquid biopsy from Biocept gives you a new tool for profiling breast cancer—with a simple blood ...
ByBiocept based in San Diego, CALIFORNIA (USA)
Standard treatment for advanced colorectal cancer generally involves surgical resection and chemotherapy. However, the recent emergence of targeted therapies, particularly those that inhibit EGFR, has provided treatment options that extend survival for a subset of patients. Unfortunately, this benefit does not extend to patients whose tumors contain mutations in EGFR signaling components KRAS and BRAF, which together represent 50% of all colorectal cancers. This makes characterizing these molecular markers an ...
ByBiocept based in San Diego, CALIFORNIA (USA)